Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin LymphomaB-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Waldenstrom macroglobulinemia, cardiovascular disorder, follicular lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, monoclonal gammopathy, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 12025-12-10NCT05602363

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Carna Biosciences, Inc.2

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
American Oncology PartnersFort WayneUnited States1
Duke UniversityDurhamUnited States91
Moffitt Cancer CenterTampaUnited States523
Mount Sinai Comprehensive Cancer CenterMiami BeachUnited States26
Northwestern Memorial HospitalChicagoUnited States1
Oncology ConsultantsHoustonUnited States22
Optum Medical Care PCWestburyUnited States1
Taylor Cancer Research CenterMaumeeUnited States24
The Medical College of WisconsinMilwaukeeUnited States1
UC Irvine HealthOrangeUnited States20
University of Maryland Medical Center - Greenebaum Comprehensive Cancer CenterBaltimoreUnited States1
University of Massachusetts Memorial Medical CenterWorcesterUnited States14
University of Texas MD Anderson Cancer CenterHoustonUnited States192